Showing results 19 to 22 of 22
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer Journal:Clinical and Translational Medicine | 2021 | ||
Serial early post-IMRT undetectable plasma EBV DNA to predict outcomes in non-metastatic nasopharyngeal cancer Proceeding/Conference:Journal of Clinical Oncology | 2015 | ||
Targeting CHK2 to reverse tamoxifen resistance by reducing BQ323636.1 in ER-positive breast cancer Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021 | 2021 | ||
The addition of pretreatment plasma Epstein–Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification Journal:International Journal of Cancer | 2019 |